Impact of salvage chemotherapy after immune checkpoint inhibitor for recurrent or metastatic head and neck cancer.
Matoba T, Minohara K, Kawakita D, Sawabe M, Takano G, Oguri K, Murashima A, Iwaki S, Tsuge H, Imaizumi S, Hojo W, Kondo A, Tsukamoto K, Iwasaki S.
Matoba T, et al. Among authors: imaizumi s.
Head Neck. 2024 Jan 16. doi: 10.1002/hed.27643. Online ahead of print.
Head Neck. 2024.
PMID: 38229255